Linezolid
Nosocomial pneumonia, Community-acquired pneumonia, Complicated skin and skin structure infections, Uncomplicated skin and skin structure infections, Vancomycin-resistant Enterococcus faecium infections
Indications
- Nosocomial pneumonia
- Community-acquired pneumonia
- Complicated skin and skin structure infections
- Uncomplicated skin and skin structure infections
- Vancomycin-resistant Enterococcus faecium infections
Adult dosing
- pneumonia complicated skin vre: dose: 600; unit: mg; route: PO, IV; interval: every 12 hours for 10 to 28 days; fixed: true; labelExcerpt: 600 mg intravenous or oral every 12 hours
- uncomplicated skin: dose: 400; unit: mg; route: PO; interval: every 12 hours for 10 to 14 days; fixed: true; labelExcerpt: Adults: 400 mg oral every 12 hours
Pediatric dosing
- pneumonia complicated skin vre: dose: 10; unit: mg/kg; route: PO, IV; interval: every 8 hours for 10 to 28 days; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: 10 mg/kg intravenous or oral every 8 hours
- uncomplicated skin under 5: dose: 10; unit: mg/kg; route: PO; interval: every 8 hours for 10 to 14 days; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: less than 5 yrs: 10 mg/kg oral every 8 hours
- uncomplicated skin 5 to 11: dose: 10; unit: mg/kg; route: PO; interval: every 12 hours for 10 to 14 days; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: 5–11 yrs: 10 mg/kg oral every 12 hours
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Known hypersensitivity
- Use with MAOIs
Clinical pearls
- Monitor complete blood counts weekly, especially if treated > 2 weeks.
- Do not use with MAOIs or within two weeks of MAOI discontinuation.
- Increased risk of serotonin syndrome when used with serotonergic agents.
- Optic and peripheral neuropathy reported primarily with therapy > 28 days.
Source and review
- DailyMed label (linezolid, Zyvox), Set ID 6e70e63b-bfd5-478d-a8ee-8ba22c9efabd, effective 2026-11-03. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties